Parkinson’s Disease

Congratulations to Drs. Kara A. Johnson, Kelly D. Foote, Michael S. Okun, and Joshua K. Wong on the publication of “Proceedings of the 11th Annual Deep Brain Stimulation Think Tank: Pushing the Forefront of Neuromodulation with Functional Network Mapping, Biomarkers for Adaptive DBS, Bioethical Dilemmas, AI-Guided Neuromodulation, and Translational Advancements,”…

Congratulations to Drs. Alfonso Enrique Martinez-Nunez, and Michael Okun, on the publication of “Emerging therapies for neuromodulation in Parkinson’s disease,” which appears in the December 28th issue of Neurotherapeutics. Abstract Parkinson’s disease is characterized by its cardinal motor symptoms: bradykinesia, rigidity, tremor, and postural instability. The underlying physiological dysfunction includes basal…

Congratulations to Matthew A. Remz, Joshua K. Wong, Justin D. Hilliard, Tracy Tholanikunnel, Ashley E. Rawls and Michael S. Okun on the publication of “Identification and Management of Persistent Stimulation-Induced Dyskinesia Associated with STN DBS: The See-Saw Dilemma,” which was published in the August 28th edition of Tremor and Other…

Congratulations Drs. Okun, Foote, Ramirez-Zamora, and Gunduz on the publication of “Weight and survival after deep brain stimulation for Parkinson’s disease,” which appears in the August 17th issue of Parkinsonism and Related Disorders. Abstract Background Weight loss in Parkinson’s disease (PD) is common and associated with increased mortality. The…

Hallucinations and delusions from psychosis are not uncommon for people living with Parkinson’s disease (PD). According to the Parkinson’s Foundation, between 20-40% of people living with PD report hallucinations with the likelihood increasing as someone living with PD ages. The only FDA-approved medication for hallucinations in Parkinson disease is pimavanserin (commonly sold…

Congratulations to Winston T. Chu, Jesse Hall, Anjela Gurrala, Alexander Becsey, Shreya Raman, Michael S. Okun, Catherine T. Flores, Benoit I. Giasson, David E. Vaillancourt, and Vinata Vedam-Mai on the publication of “Evaluation of an Adoptive Cellular Therapy-Based Vaccine in…

Congratulations to Drs Hubert H. Fernandez, Michael S. Okun, and Dawn Bowers on the publication of “A pilot trial of dopamine replacement for dynamic facial expressions in Parkinson’s disease,” which was published in the October 20th issue of Movement Disorders Clinical Practice.

Congratulations to Dr. Okun on the publication of “Muhammad Ali and Young-Onset Idiopathic Parkinson Disease—The Missing Evidence.”  This paper was published in the October 24th edition of JAMA Neurology. Following Muhammad Ali’s death, there has been persistent dialogue about the degree to which Parkinson disease vs repetitive boxing-related head trauma…

Congratulations Drs. JanineLopes, Kelly D.Foote, Michael S. Okun on the publication of “Distinct roles of the human subthalamic nucleus and dorsal pallidum in Parkinson’s disease impulsivity,” in the March issue of Biological…

Congratulations Dr Nikolaus McFarland, on the publication of “The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism,” in the March 1 issue of Nature Portfolio Journals.   Abstract The Trial of Parkinson’s And Zoledronic acid (TOPAZ, https://clinicaltrials.gov/ct2/show/NCT03924414) is a unique collaboration between experts…